You have read all your free articles, to continue reading subscribe to read the rest of this content.
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer at Novo Nordisk, talks about the Danish pharma giant’s drug-development strategy, the new era of diabetes care and his 25 year-long passion for his job. The changing diabetes market, with increasing competition and highAlready a subscriber Login You have read…
Academia and business don’t always mix, but Agnete B. Fredriksen of Norway has found the formula. While doing research for her doctorate degrees at the University of Oslo, Fredriksen and co-workers invented a technology to create vaccines that help the body’s immune system fight cancer and otAlready a subscriber Login…
For the past 14 years Jutta Heix has been an important cog in the wheel in accelerating the development of new cancer treatments and diagnostics – connecting and helping innovators and putting Norwegian oncology on the global map. Oslo Cancer Cluster (OCC), founded in 2006, has developed over tAlready a…
“It is with great regret and sadness we announce this very tragic and unexpected information," says the Board of Directors, Karo Pharma. “Anders Lönner has suddenly and unexpected passed away. Our thoughts go to his family and those closest to him." Anders Lönner joined Karo Pharma as ExecuAlready a subscriber…
